Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity

doi:10.4254/wjh.124108

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 8

This Article

(2)

(3)

(0)

(1)

(48)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. Aug 27, 2026; 18(8): 124108
Published online Aug 27, 2026. doi: 10.4254/wjh.124108

Open in New Tab Full Size Figure Download Figure

Figure 1 Study population flow chart. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus.

Open in New Tab Full Size Figure Download Figure

Figure 2 Distribution of patients within the functional cure and chronic hepatitis B virus groups according to socioeconomic status, country of birth, gender and ethnicity. A: Socioeconomic status distribution by hepatitis B surface antigen (HBsAg) status; B: Gender distribution by HBsAg status; C: Country of birth distribution by HBsAg status; D: Ethnicity distribution by HBsAg status. HBsAg: Hepatitis B surface antigen; SES: Socioeconomic status; FC: Functional cure; CHB: Chronic hepatitis B virus.

Open in New Tab Full Size Figure Download Figure

Figure 3 Comparison of liver enzymes and total bilirubin during acute hepatitis B virus presentation in patients who achieved functional cure and patients with chronic hepatitis B virus. HBsAg: Hepatitis B surface antigen; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma glutamyl transferase; Alk Phos: Alkaline phosphatase; FC: Functional cure; CHB: Chronic hepatitis B virus.

Citation: Yardeni D, Gershbaum Tobin J, Itkowitz B, Lipnizkiy I, Abu Juma’a A, Abu-Freha N, Keren-Naus A, Turgeman M, Nevo-Shor A, Gish RG, Etzion O. Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity. World J Hepatol 2026; 18(8): 124108
URL: https://www.wjgnet.com/1948-5182/full/v18/i8/124108.htm
DOI: https://dx.doi.org/10.4254/wjh.124108

Yardeni D, Gershbaum Tobin J, Itkowitz B, Lipnizkiy I, Abu Juma’a A, Abu-Freha N, Keren-Naus A, Turgeman M, Nevo-Shor A, Gish RG, Etzion O. Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity. World J Hepatol 2026; 18(8): 124108 [DOI: 10.4254/wjh.124108]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.